Sana Biotechnology Announces Completion of Initial Financing
top of page
Companies in the News
SEATTLE — Sana Biotechnology, Inc. (Sana), focused on engineering cells as medicines for patients, announced today the funding of all...
- Jun 17, 2020
Indigo Places #3 on CNBC’s Disruptor 50 2020 List
Founders: David Perry, Geoffrey von Maltzahn and Noubar Afeyan CEO: David Perry Launched: 2014 Headquarters: Boston Funding: $850 million...
- Jun 15, 2020
Magenta Enters Collaboration Agreement with Beam to Further Explore MGTA-117
Cambridge-based Magenta Therapeutics announced today that it has entered a non-exclusive research and clinical collaboration agreement...
- May 29, 2020
Gossamer Bio Announces Early Encouraging Safety and Biomarker Data from Phase 1/2 Study of GB1275 at
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering,...
- May 19, 2020
Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases
Multi-Target Collaboration Leverages Vividion's Screening Platform to Discover and Develop Highly Selective Small Molecules for E3...
- May 13, 2020
Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial R
Alpha-1 Antitrypsin Deficiency Program Demonstrates More than Four-Fold Increase in Circulating Levels of Functional Protein Following...
- Apr 30, 2020
eFFECTOR’s Zotatifin Demonstrates in vitro Anti-SARS-CoV-2 Activity in Independent International Stu
SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., today announced that preliminary results from an independent...
- Apr 27, 2020
eFFECTOR’s Zotatifin (eFT226) Inhibited Tumor Growth and Caused Tumor Regression Across Diverse Rece
Study Presented in Virtual Session at AACR Annual Meeting Provides Evidence of Potential for Zotatifin to Drug an Important Class of...
- Apr 6, 2020
GlaxoSmithKline injects US$250mln into US biotech Vir in coronavirus treatment collaboration
Vir's has two candidates that have proved highly potent in neutralising SARS-CoV-2 in live virus-cellular assays GlaxoSmithKline PLC...
bottom of page